In organ culture, 5-ASA inhibited synthesis of PGE2 to a greater extent than sulphasalazine and sulphapyridine,2 but this result could have arisen through a non-specific effect on cell viability. In another report, a specific ability to inhibit the prostaglandin synthetase (cyclooxygenase) of human rectal mucosa was shown for sulphasalazine but its cleavage products were not investigated.
SUMMARY Miniaturised methods have been used to construct dose-reponse curves for the effects of inhibitory drugs on prostaglandin synthesis using individual rectal biopsies obtained from patients with ulcerative colitis. The potency of different drugs has been compared. Sulphasalazine. 5 amino salicylic acid and N-acetyl 5-ASA inhibited prostaglandin synthesis at high concentration, but sulphapyridine and prednisolone did not. Indomethacin and flurbiprofen were considerably more potent inhibitors. These data imply that sulphasalazine does not act by simple inhibition of prostaglandin synthesis but leave open the possibility that sulphsalazine or 5-ASA may be inhibitors of the synthesis of related lipoxygenase products.
Although sulphasalazine is widely used in the management of ulcerative colitis its mode of action remains unclear. Increased prostaglandin synthesis occurs during active ulcerative colitis.'-' and it has been suggested that sulphasalazine or one of its cleavage products -5 amino salicvlic acid (5-ASA) or sulphapyridine -may exert anti-inflammatory activity by inhibiting prostaglandin synthesis.2
In organ culture, 5-ASA inhibited synthesis of PGE2 to a greater extent than sulphasalazine and sulphapyridine,2 but this result could have arisen through a non-specific effect on cell viability. In another report, a specific ability to inhibit the prostaglandin synthetase (cyclooxygenase) of human rectal mucosa was shown for sulphasalazine but its cleavage products were not investigated.
In the present study we compared the potency of sulphasalazine and its cleavage products with indomethacin and flurbiprofen as inhibitors of prostaglandin synthetase using individual rectal biopsies obtained from untreated patients with quiescent ulcerative colitis. High concentrations of 5-ASA inhibited synthesis of PGE, (mean 1C50 2.29x 1()-2 M (3.9 mg/ml)). As shown in Fig. 1 its potency was similar in all four individuals investigated. The potency of N-acetyl 5-ASA and sulphasalazine was similar to that of 5-ASA but indomethacin and flurbiprofen were about five orders of magnitude more potent. The overall mean values for all the subjects have been used to compare these drugs graphically in Fig. 2 .
Discussion
These data show that sulphasalazine and 5-ASA but not sulphapyridine can inhibit the prostaglandin synthetase activity of human rectal mucosa. The Table) have been averaged for each point shown.
HuwknV antd 1True/love results parallel the clinical observation that sulphasalazine and 5 amino salicylic acid when administered by enema to patients with active disease are therapeutically potent, while sulphapyridine is not.7 Prednisolone, which has anti-inflammatory properties in ulcerative colitis, exerts no pharmacological inhibition of prostaglandin synthetase but has previously been shown to reduce basal prostaglandin synthesis in intact human rectal mucosa maintained in organ culture.' This may be attributed to its ability in living cells to induce synthesis of a polypeptide, macrocortin, which inhibits the release of free arachidonic acid." In addition, one of us has proposed that it may also induce synthesis of a local cyclooxygenase inhibitor." Neither of these properties would, however, apply with homogenates in vitro.
The concentrations of 5-ASA and sulphasalazine required to inhibit prostaglandin synthesis are high and the data are open to the possible criticism that this may not reflect true competitive inhibition. The concentrations of 5-ASA required for inhibition, however, are similar to those measured in the faeces of patients taking sulphasalazine.i N-acetyl 5-ASA is a derivative of 5-ASA which is therapeutically active when adminstered topically;9 its potency as an inhibitor of prostaglandin synthesis is similar to that of 5-ASA.
There are at present two main views as to the role of prostaglandins in ulcerative colitis. The present data support the interpretation that prostaglandin synthesis contributes to an excessive inflammatory reaction and that inhibition of this synthesis is therefore desirable. The data also show, however, that indomethacin and flurbiprofen are more potent than 5-ASA as inhibitors of prostaglandin synthesis by human rectal mucosa but they do not appear to be effective agents in the treatment of ulcerative colitis. "" A detailed analysis of treatment of active ulcerative colitis by flurbiprofen showed that this drug had a number of deleterious effects.' 2 Such results have led to the alternative view that prostaglandins may be 'cyto-protective' in ulcerative colitis. In support of this proposal, it has been shown that sulphasalazine (but not 5-ASA) can inhibit prostaglandin metabolism in rabbit colon,'2 and that 5-ASA can lead to enhanced prostacyclin (PGI2) synthesis by human rectal mucosa. 13 These data show that, in some circumstances, sulphasalazine and 5-ASA might lead to enhanced rather than reduced levels of mucosal prostaglandins. There is at present, however, very little direct evidence that this would lead to a 'cyto-protective' effect in the colon such as occurs with prostaglandins in the stomach. Furthermore, where 5-ASA was shown to enhance prostcyclin synthesis, inhibition was observed at the higher concentrations which were similar to those found in the faeces, and to those used in the experiments reported here. 3 A third theory can be proposed as to the mode of action of sulphasalazine in ulcerative colitis. Weak inhibitors of prostaglandin synthetase have been shown to inhibit lipoxygenase pathways which may lead to the production of non-prostaglandin hydroxy acid products of arachidonic acid metabolism; '4 
